← Back to headlines
Roche Multiple Sclerosis Drug Meets Main Goal in Late-Stage Trial - WSJ
Roche Multiple Sclerosis Drug Meets Main Goal in Late-Stage Trial WSJ
2 Mar, 16:31 — 2 Mar, 16:31
Sources
Showing 1 of 1 sources
Roche Multiple Sclerosis Drug Meets Main Goal in Late-Stage Trial WSJ